OrthoPediatrics (KIDS) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

OrthoPediatrics Revenue Highlights


Latest Revenue (Y)

$148.73M

Latest Revenue (Q)

$52.80M

Main Segment (Y)

Trauma and Deformity

Main Geography (Y)

UNITED STATES

OrthoPediatrics Revenue by Period


OrthoPediatrics Revenue by Year

DateRevenueChange
2023-12-31$148.73M21.62%
2022-12-31$122.29M24.72%
2021-12-31$98.05M37.95%
2020-12-31$71.08M-2.03%
2019-12-31$72.55M26.05%
2018-12-31$57.56M26.17%
2017-12-31$45.62M22.31%
2016-12-31$37.30M20.30%
2015-12-31$31.00M30.91%
2014-12-31$23.68M-

OrthoPediatrics generated $148.73M in revenue during NA 2023, up 21.62% compared to the previous quarter, and up 258.40% compared to the same period a year ago.

OrthoPediatrics Revenue by Quarter

DateRevenueChange
2024-06-30$52.80M18.16%
2024-03-31$44.69M18.80%
2023-12-31$37.61M-5.90%
2023-09-30$39.97M1.04%
2023-06-30$39.56M25.23%
2023-03-31$31.59M1.92%
2022-12-31$30.99M-11.32%
2022-09-30$34.95M6.14%
2022-06-30$32.93M40.62%
2022-03-31$23.42M-5.63%
2021-12-31$24.81M-1.06%
2021-09-30$25.08M-6.05%
2021-06-30$26.70M24.38%
2021-03-31$21.46M13.41%
2020-12-31$18.92M-14.78%
2020-09-30$22.20M63.36%
2020-06-30$13.59M-16.89%
2020-03-31$16.36M-13.70%
2019-12-31$18.95M-8.64%
2019-09-30$20.74M13.98%
2019-06-30$18.20M24.18%
2019-03-31$14.66M0.60%
2018-12-31$14.57M-7.91%
2018-09-30$15.82M4.93%
2018-06-30$15.08M24.67%
2018-03-31$12.09M3.54%
2017-12-31$11.68M-5.61%
2017-09-30$12.38M4.86%
2017-06-30$11.80M20.90%
2017-03-31$9.76M3.65%
2016-12-31$9.42M-7.07%
2016-09-30$10.13M4.77%
2016-06-30$9.67M19.86%
2016-03-31$8.07M30.60%
2015-03-31$6.18M-

OrthoPediatrics generated $52.80M in revenue during Q2 2024, up 18.16% compared to the previous quarter, and up 167.16% compared to the same period a year ago.

OrthoPediatrics Revenue Breakdown


OrthoPediatrics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Trauma and Deformity$106.78M$85.06M$65.83M$47.68M$49.37M
ACL Reconstruction and Other$4.02M$3.81M$4.17M$2.66M$1.70M
Spine$37.93M$33.43M$28.05M$20.74M$21.48M

OrthoPediatrics's latest annual revenue breakdown by segment (product or service), as of Dec 23: Trauma and Deformity (71.79%), Spine (25.50%), and ACL Reconstruction and Other (2.70%).

Quarterly Revenue by Product

Product/ServiceMar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
Trauma And Deformity$33.30M$28.81M$27.51M$23.39M$23.89M---------------
Spine$10.20M$9.66M$10.30M$10.89M$7.07M$8.04M$9.98M$9.42M$5.98M$7.17M$7.27M$7.66M$6.64M$4.89M------
Sports Medicine And Other$1.18M$862.00K$1.15M$1.12M$1.08M$939.00K$918.00K$996.00K$1.10M-----------
Trauma and Deformity-------$22.57M$16.52M$16.82M$17.93M$14.55M$14.97M$9.22M$13.63M-----
SpineMember------------$5.95M$6.55M$3.84M$3.71M$6.47M$5.87M--
SportsMedicineandOtherMember------------$959.00K$681.00K$537.00K$435.00K$438.00K$447.00K--
TraumaandDeformityMember----------------$12.21M$13.84M$11.89M-

OrthoPediatrics's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Trauma And Deformity (74.53%), Spine (22.83%), and Sports Medicine And Other (2.64%).

OrthoPediatrics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20Dec 19
UNITED STATES$111.01M$92.42M$77.78M$62.97M$55.05M
Non-US$37.72M$29.87M$20.27M$8.11M$17.50M

OrthoPediatrics's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (74.64%), and Non-US (25.36%).

Quarterly Revenue by Country

CountryMar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Sep 21Jun 21Mar 21Sep 20Jun 20Mar 20Sep 19Jun 19Mar 19Dec 18Sep 18
UNITED STATES$34.30M$28.26M$29.36M$29.59M$23.80M$22.73M$26.54M$24.96M$18.19M$19.35M$21.74M$16.84M$19.58M$12.15M$13.38M$16.79M$13.85M$10.27M$10.93M$12.42M
Non-US$10.38M$9.35M$10.61M$9.97M$7.79M$8.26M$8.41M$7.97M$5.23M$5.72M$4.96M$4.62M$2.62M$1.45M$2.97M$3.96M$4.35M$4.39M$3.64M$3.40M

OrthoPediatrics's latest quarterly revenue breakdown by geography, as of Mar 24: UNITED STATES (76.77%), and Non-US (23.23%).

OrthoPediatrics Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
CNMDCONMED$1.24B$332.10M
LIVNLivaNova$1.15B$318.60M
IRTCiRhythm$492.68M$148.05M
GKOSGlaukos$314.71M$95.69M
FNAParagon 28$216.39M$61.02M
KIDSOrthoPediatrics$148.73M$52.80M
SIBNSI-BONE$138.89M$39.97M
SRDXSurmodics$132.58M$30.34M
SGHTSight Sciences$81.06M$21.37M
LUNGPulmonx$68.67M$20.78M
NPCENeuroPace$65.42M$18.12M
CVRXCVRx$39.30M$11.81M
OSAProSomnus$27.65M$7.46M
OFIXOrthofix Medical$100.00K$198.62M

KIDS Revenue FAQ


OrthoPediatrics's yearly revenue for 2023 was $148.73M, representing an increase of 21.62% compared to 2022. The company's yearly revenue for 2022 was $122.29M, representing an increase of 24.72% compared to 2021. KIDS's yearly revenue for 2021 was $98.05M, representing an increase of 37.95% compared to 2020.

OrthoPediatrics's quarterly revenue for Q2 2024 was $52.8M, a 18.16% increase from the previous quarter (Q1 2024), and a 33.48% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $44.68M, a 18.80% increase from the previous quarter (Q4 2023), and a 41.46% increase year-over-year (Q1 2023). KIDS's quarterly revenue for Q4 2023 was $37.61M, a -5.90% decrease from the previous quarter (Q3 2023), and a 21.36% increase year-over-year (Q4 2022).

OrthoPediatrics's revenue growth rate for the last 3 years (2021-2023) was 51.69%, and for the last 5 years (2019-2023) was 105.00%.

OrthoPediatrics's revenue streams in c 23 are Trauma and Deformity, ACL Reconstruction and Other, and Spine. Trauma and Deformity generated $106.78M in revenue, accounting 71.79% of the company's total revenue, up 25.54% year-over-year. ACL Reconstruction and Other generated $4.02M in revenue, accounting 2.70% of the company's total revenue, up 5.57% year-over-year. Spine generated $37.93M in revenue, accounting 25.50% of the company's total revenue, up 13.48% year-over-year.

For the fiscal year ending Dec 23, the largest source of revenue of OrthoPediatrics was Trauma and Deformity. This segment made a revenue of $106.78M, representing 71.79% of the company's total revenue.